Eczematous Skin Disease and Recall of Past Diagnoses: Implications for Smallpox Vaccination

Annals of Internal Medicine

Volumn 139, Issue 1, 2003, Pages

  Naleway, Allison L ^b   Belongia, Edward A ^a   Greenlee, Robert T ^b   Kieke Jr , Burney A ^b   Chen, Robert T ^b   Shay, David K ^b  

^a MARSHFIELD CLINIC   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

SMALLPOX VACCINE;

ADOLESCENT; ADULT; ARTICLE; ATOPIC DERMATITIS; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE SEVERITY; DRUG CONTRAINDICATION; ECZEMA; ECZEMA VACCINATUM; HEALTH SURVEY; HUMAN; INFANT; MAJOR CLINICAL STUDY; NEWBORN; PATIENT SELECTION; POPULATION RESEARCH; PRIORITY JOURNAL; RASH; SCREENING; SMALLPOX; VACCINATION; VACCINATION REACTION; CHILD; HERPES SIMPLEX; INTERVIEW; METHODOLOGY; MIDDLE AGED; PRESCHOOL CHILD; PREVALENCE; RECALL; RISK FACTOR; TELEPHONE; UNITED STATES;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; DERMATITIS, ATOPIC; ECZEMA; HUMANS; INFANT; INFANT, NEWBORN; INTERVIEWS; KAPOSI VARICELLIFORM ERUPTION; MENTAL RECALL; MIDDLE AGED; PREVALENCE; RISK FACTORS; SMALLPOX VACCINE; TELEPHONE; VACCINATION; WISCONSIN;

EID: 1642576126     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-139-1-200307010-00006     Document Type: Article

References (33)

1. Bicknell WJ. The case for voluntary smallpox vaccination. N Engl J Med. 2002;346:1323-5. [PMID: 11923492]
2. Bicknell WJ. Smallpox and smallpox vaccination [Letter]. N Engl J Med. 2002;347:691-2.
3. Lane JM. Smallpox and smallpox vaccination [Letter]. N Engl J Med. 2002;347:691-2. [PMID: 12200562]
4. Henderson DA, Inglesby TV, Bartlett JG, Ascher MS, Eitzen E, Jahrling PB, et al. Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA. 1999;281:2127-37. [PMID: 10367824]
5. Recommendations for using smallpox vaccine in a pre-event vaccination program: supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Healthcare Infection Control Practices Advisory Committee (HICPAC). MMWR Dispatch. 2003;52:1-16. Accessed at www.cdc.gov/mmwr/preview/mmwrhtml/m2d226.htm on 19 March 2003.
6. Update: adverse events following smallpox vaccination-United States, 2003. MMWR Morb Mortal Wkly Rep. 2003;52:278-82.
7. Breman JG, Henderson DA. Diagnosis and management of smallpox. N Engl J Med. 2002;346:1300-8. [PMID: 11923491]
8. Lane JM, Ruben FL, Neff JM, Millar JD. Complications of smallpox vaccination, 1968: results of ten statewide surveys. J Infect Dis. 1970;122:303-9. [PMID: 4396189]
9. Vaccinia (smallpox) vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2001. MMWR Morb Mortal Wkly Rep. 2001;50(RR-10):1-26.
10. Kemper AR, Davis MM, Freed GL. Expected adverse events in a mass smallpox vaccination campaign. Eff Clin Pract. 2002;5:84-90. [PMID: 11990216]
11. Greenberg M. Complications of vaccination against smallpox. Am J Dis Child. 1948;76:492-502.
12. Copeman PW, Wallace HJ. Eczema vaccinatum. Br J Med. 1964;2:906-8.
13. Waddington E, Bray PT, Evans AD, Richards ID. Cutaneous complications of mass vaccination against smallpox in South Wales 1962. Annual Report and Transactions of the London Dermatologic Society. 1964;50:22-41.
14. Goldstein JA, Neff JM, Lane JM, Koplan JP. Smallpox vaccination reactions, prophylaxis, and therapy of complications. Pediatrics. 1975;55:342-7. [PMID: 238178]
15. Lane JM, Ruben FL, Neff JM, Millar JD. Complications of smallpox vaccination, 1968. N Engl J Med. 1969;281:1201-8. [PMID: 4186802]
16. Neff JM, Lane JM, Fulginiti VA, Henderson DA. Contact vaccinia-transmission of vaccinia from smallpox vaccination. JAMA. 2002;288:1901-5. [PMID: 12377090]
17. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Dermatovener. 1980;92:44-7.
18. Laughter D, Istvan JA, Tofte SJ, Hanifin JM. The prevalence of atopic dermatitis in Oregon schoolchildren. J Am Acad Dermatol. 2000;43:649-55. [PMID: 11004621]
19. American Academy of Dermatology. Eczema/atopic dermatitis. Accessed at www.aad.org/pamphlets/eczema.html on 28 January 2003.
20. Neame RL, Berth-Jones J, Kurinczuk JJ, Graham-Brown RA. Prevalence of atopic dermatitis in Leicester: a study of methodology and examination of possible ethnic variation. Br J Dermatol. 1995;132:772-7. [PMID: 7772484]
21. Williams H. Disease definition and measures of disease frequency. J Am Acad Dermatol. 2001;45:S33-6. [PMID: 11423870]
22. Schultz Larsen F, Diepgen T, Svensson A. The occurrence of atopic dermatitis in north Europe: an international questionnaire study. J Am Acad Dermatol. 1996;34:760-4. [PMID: 8632070]
23. Worldwide variation in prevalence of symptoms of asthma, allergic rhinocon-junctivitis, and atopic eczema: ISAAC, The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Lancet. 1998;351:1225-32. [PMID: 9643741]
24. Herd RM, Tidman MJ, Prescott RJ, Hunter JA. Prevalence of atopic eczema in the community: the Lothian Atopic Dermatitis study. Br J Detmatol. 1996;135:18-9. [PMID: 8776352]
25. Ellis CN, Drake LA, Prendergast MM, Abramovits W, Boguniewicz M, Daniel CR, et al. Cost of atopic dermatitis and eczema in the United States. J Am Acad Dermatol. 2002;46:361-70. [PMID: 11862170]
26. Kay J, Gawkrodger DJ, Mortimer MJ, Jaron AG. The prevalence of childhood atopic eczema in a general population. J Am Acad Dermatol. 1994;30:35-9. [PMID: 8277028]
27. McNally NJ, Williams HC, Phillips DR, Strachan DP. Is there a geographic variation in eczema prevalence in the UK? Evidence from the 1958 British Birth Cohort Study. Br J Dermatol. 2000;142:712-20. [PMID: 10792221]
28. DeStefano F, Eaker ED, Broste SK, Nordstrom DL, Peissig PL, Vierkant RA, et al. Epidemiologic research in an integrated regional medical care system: the Marshfield Epidemiologic Study Area. J Clin Epidemiol. 1996;49:643-52. [PMID: 8656225]
29. Williams HC, Burney PG, Hay RJ, Archer CB, Shipley MJ, Hunter JJ, et al. The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis. I. Derivation of a minimum set of discriminators for atopic dermatitis. Br J Dermatol. 1994;131:383-96. [PMID: 7918015]
30. Breslow NE, Day NE. Statistical Methods in Cancer Research. Volume II. The Design and Analysis of Cohort Studies. Lyon, France: International Agency for Research on Cancer; 1987.
31. Hastie TJ, Tibshirani RJ. Generalized Additive Models. New York: Chapman & Hall; 1990.
32. Centers for Disease Control and Prevention. Smallpox vaccination report. Status and adverse events. Accessed at www.cdc.gov/od/oc/media/smpxrprt.htm on 10 April 2003.
33. Department of Defense. Smallpox safety summary. Accessed at www.smallpox .army.mil/media/pages/SPSafetySum.asp on 10 April 2003.